Cargando…

EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19

Detalles Bibliográficos
Autores principales:	Seinfeld, J, Sobrevilla, A, Rosales, ML, Ibañez, M, Munayco, C, Londono, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747481/ http://dx.doi.org/10.1016/j.jval.2022.09.1025

Ejemplares similares

Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru
por: Seinfeld, Janice, et al.
Publicado: (2022)

Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines
por: Gentile, Angela, et al.
Publicado: (2023)

Kawasaki disease in an infant after administration of hexavalent vaccine
por: Almeshary, Meshal Z., et al.
Publicado: (2021)

Cost minimization analysis of a hexavalent vaccine in Argentina
por: Olivera, Ignacio, et al.
Publicado: (2023)

Etale homotopy of simplicial schemes (AM-104)
por: Friedlander, Eric M
Publicado: (1983)

Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity
por: Szwejser-Zawislak, Ewa, et al.
Publicado: (2022)

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b vaccine; Infanrix™ hexa: Twelve years of experience in Italy
por: Baldo, Vincenzo, et al.
Publicado: (2014)

Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants
por: Wu, Zhiwei, et al.
Publicado: (2022)

What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?
por: Lloyd, Andrew J, et al.
Publicado: (2015)

Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
por: Klein, Nicola P., et al.
Publicado: (2019)

La filosofia contemporanea en el Peru : estudios, reseñas y notas sobre su desarrollo y situacion actual
por: Sobrevilla, David, 1938-
Publicado: (1996)

Acellular Pertussis Vaccine Components: Today and Tomorrow
por: Dewan, Kalyan K., et al.
Publicado: (2020)

Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine
por: Olivera, Ignacio, et al.
Publicado: (2020)

Synthesis, Characterization and Hexavalent Chromium Adsorption Characteristics of Aluminum- and Sucrose-Incorporated Tobermorite
por: Zhao, Zhiguang, et al.
Publicado: (2017)

Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines
por: Vesikari, Timo, et al.
Publicado: (2019)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
por: Möller, Jens, et al.
Publicado: (2019)

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy
por: Alghounaim, Mohammad, et al.
Publicado: (2022)

An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine
por: Rose, Markus A, et al.
Publicado: (2013)

Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries
por: Mahmood, Kutub, et al.
Publicado: (2013)

Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea
por: Min, Serim, et al.
Publicado: (2023)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Oral Diazepam in Febrile Seizures Following Acellular Pertussis Vaccination
por: Ghazavi, Mohammadreza, et al.
Publicado: (2019)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

The influence of geographic and climate factors on the timing of dengue epidemics in Perú, 1994-2008
por: Chowell, Gerardo, et al.
Publicado: (2011)

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines
por: Giambi, Cristina, et al.
Publicado: (2008)

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
por: Madhi, Shabir A., et al.
Publicado: (2019)

Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Italy: a survey of attitudes and expectations
por: ICARDI, GIANCARLO, et al.
Publicado: (2020)

Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
por: Cuesta Esteve, Inmaculada, et al.
Publicado: (2021)

Hexavalent chromium (Contaminants)
Publicado: (2019)

EPH155 A Systematic Review of the Impact of Vaccination on Long COVID
por: Thompson, JY, et al.
Publicado: (2022)

The spatial and temporal patterns of falciparum and vivax malaria in Perú: 1994–2006
por: Chowell, Gerardo, et al.
Publicado: (2009)

Recommendations for modernizing infant vaccination schedules with combination vaccines in Colombia and Peru
por: Torres-Martinez, Carlos, et al.
Publicado: (2023)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Acellular pertussis vaccine efficacy: An updated systematic review and meta –analysis
por: Mansour-Ghanaei, Roxana, et al.
Publicado: (2016)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
por: Brandal, Lin T., et al.
Publicado: (2022)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k2n05p4alb2do15vtq65b6l6pu